PI of a melanoma research group. Cancer Center Deputy Director. Tweets are my own
Philadelphia, PA
Joined February 2018
- Tweets656
- Following427
- Followers1.2K
- Likes10.1K
Aplin Lab - Cancer Research retweeted
📍 We’re headed to Philadelphia!
ACIS will be attending AND presenting at the 2026 Uveal Melanoma Patient & Caregiver Educational Symposium on Sept. 19. 💙
Patients & caregivers, we hope to see you there!
Register by Sept. 4: skccext.jefferson.edu/events…
Aplin Lab - Cancer Research retweeted
The 2025 SMR Congress is just around the corner!
Join us in Amsterdam, NL, October 25–28, for an outstanding lineup of keynote speakers.
Explore the full program and register today – smrcongress.org
#SMRCongress #MedicalResearch #CancerResearch #Melanoma #MelanomaResearch
Aplin Lab - Cancer Research retweeted
We are proud to announce the newest recipients of the MRF’s research awards: five Career Development Awards (CDA), four Established Investigator Awards (EIA) and the MRFBC Pilot Translational Award.
These grants will support groundbreaking projects in earlier diagnosis of lethal melanoma, innovative therapies for acral and mucosal melanoma, new strategies to overcome drug resistance and more.
Through the MRF’s Research & Science Grant Program, more than $28 million has been awarded in peer-reviewed research grants to date.
Funding is critical to advancing treatment progress for the melanoma community and we look forward to the impact these dedicated researchers will bring to the future of melanoma patients.
Learn more about MRF funded research here: buff.ly/wgwDTZt
Aplin Lab - Cancer Research retweeted
Call for Last-Minute Sponsors!
Help make the 22nd Annual SMR Congress our most impactful yet. Join us in Amsterdam, Oct 25–28, 2025, and showcase your organization to top melanoma researchers, clinicians, and industry experts worldwide.
View opportunities: smrcongress.org/exhibitor-su…
Aplin Lab - Cancer Research retweeted
I feel deeply honored to receive the 2025 Dr. Josef Steiner Cancer Research Award for our work on decoding and rewiring the immune-evasive TME. It truly is a recognition of the entire team past and present as well as our collaborators and my mentors.🙌 Thank you for your trust.
Congratulations to our @obenaufa on receiving the highly prestigious Dr. Josef Steiner Cancer Research Award 2025! 🎉
Read more in this interview with Anna: imp.ac.at/news/article/anna-…
Aplin Lab - Cancer Research retweeted
The 26th Annual Paws for the Cause is happening THIS Sunday, September 14, 2025, from 9 AM to 12 PM! In addition to a one mile walk around the Fox Chase campus, participants will enjoy food, music, entertainment for children, contests and prizes, and more: bit.ly/3S4jhkI
Aplin Lab - Cancer Research retweeted
The Early Bird registration deadline in approaching on September 10, 2025! Join us October 25–28, 2025, in Amsterdam, NL for the 2025 SMR Congress — an inspiring gathering of global experts and advocates driving progress in melanoma research.
Register now: smrcongress.org/reg-2025
Aplin Lab - Cancer Research retweeted
Any cuts to the NIH budget would stifle innovation and erode the nation's position as the global leader in biomedical research. I encourage all of our members and colleagues in the U.S. to ask their representatives to protect NIH funding:
votervoice.net/AACR/Campaign…
A report from the nonpartisan Congressional Budget Office found that proposed NIH cuts could significantly lower the number of new drugs that come to market in the next three decades. Call on Congress to reject the President’s FY26 budget and #FundNIH:
brnw.ch/21wUENV
Aplin Lab - Cancer Research retweeted
Announcing the distinguished keynote speakers for the 2025 Society for Melanoma Research (SMR) Congress. Join us in Amsterdam, NL October 25-28, 2025, as we welcome global leaders in melanoma research to the keynote stage.
Visit smrcongress.org to learn more and register.
Aplin Lab - Cancer Research retweeted
Last Call: Submit your nominations for the #SMR2025 Awards by the August 1 deadline!
Lifetime Achievement Award
Outstanding Research Award
Young Investigator Award
Christopher J. Marshall Award
Visit societymelanomaresearch.org/… for additional information.
Aplin Lab - Cancer Research retweeted
The SMR 2025 Annual Congress (Amsterdam Oct 25-28) covers basic, preclinical & translational melanoma research. It is a very enjoyable conference with top faculty and now improved with ample opportunity for young investigators to learn & network. Join us! smrcongress.org
Aplin Lab - Cancer Research retweeted
The July issue of @CD_AACR is now online! The cover features work by @alex_redding_, Elda Grabocka, and colleagues (@KimmelCancerCtr) on intercellular heterogeneity of stress granules and chemotherapy response - read that and much more: aacrjournals.org/cancerdisco…
Aplin Lab - Cancer Research retweeted
Registration and abstract submission are now OPEN for the 2025 SMR Congress! Join us October 25–28 in Amsterdam, NL to hear from leading global experts in melanoma research.
Visit smrcongress.org to learn more and register.
Aplin Lab - Cancer Research retweeted
We are excited to be at the @AACR Annual Meeting in Chicago! Our researchers begin presenting their latest advances against cancer starting today at the afternoon poster session. Check out our full schedule of research #AACR25 presentations here: mcusercontent.com/4594270188…
Aplin Lab - Cancer Research retweeted
#AACR25 Laura Reynolds from our lab present at mini symposium on targeting NELFE using microbubbles in HCC.
Aplin Lab - Cancer Research retweeted
Melanoma resists BRAF-targeted treatments, but combining avutometinib with FAK inhibitors may help overcome it.
MCC's AD of Basic Science, @SilvioGutkind, explores this in a recent @Cancer_Cell publication: bit.ly/4bm57Ut.
Aplin Lab - Cancer Research retweeted
Putting a focus on stage IV metastatic breast cancer research.
This week, the PA Breast Cancer Coalition awarded a $100,000 grant to Dr. Renato Iozzo of @jeffersonhealth as part of our ongoing commitment to advancing breast cancer research. Congratulations to Dr. Iozzo! @iozzo_v
Aplin Lab - Cancer Research retweeted
Today, we honor President Jimmy Carter’s extraordinary legacy. As a melanoma patient, he became a powerful advocate for cancer research. His journey showed the impact of immunotherapy. At MRA, we’re committed to advancing treatments so every patient has hope. #MelanomaAwareness
